Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04035759 · ClinicalTrials.gov registry record · Phase 1
Positive Affect Promotion to Empower Optimal Adherence to HIV Therapy
A Phase 1 study, sponsored by State University of New York - Downstate Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT04035759 is a Phase 1 study that has completed, run by State University of New York - Downstate Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT04035759, a Phase 1 study, has completed, sponsored by State University of New York - Downstate Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study assesses the feasibility and acceptability of the APPEAL program, a 3-session intervention designed to promote positive affect among men and women living with HIV infection. Forty participants will be randomly assigned to receive the APPEAL program, and another 40 will receive standard of care. All participants will complete self-reported assessments at baseline and at 3 and 6 months, and will have their HIV antiretroviral medication adherence monitored as part of study participation.
Interventions
- BEHAVIORAL APPEAL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-10-16 |
| Est. Completion | 2021-04-26 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04035759
The ClinicalTrials.gov registry entry for NCT04035759 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Downstate Medical Center, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which APPEAL is the first listed.
NCT04035759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04035759 about?
NCT04035759 is a clinical study titled "Positive Affect Promotion to Empower Optimal Adherence to HIV Therapy". This study assesses the feasibility and acceptability of the APPEAL program, a 3-session intervention designed to promote positive affect among men and women living with HIV infection. Forty participants will be randomly assigned to receive the APPEAL program, and another 40 will receive standard of...
What is the current status of trial NCT04035759?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2019-10-16. Estimated completion is 2021-04-26.
What interventions are being tested in trial NCT04035759?
The interventions under investigation include: APPEAL (BEHAVIORAL).
Who is sponsoring clinical trial NCT04035759?
This trial is sponsored by State University of New York - Downstate Medical Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.